Back
ESC2025 Premium Access

Valvular heart disease in Cancer patiEntS - prevAlence, Relevance, and therapeutic management - preliminary results from the CESAR study

Session: Special populations in cardio-oncology
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Speaker: Doctor L. Hauptmann (Vienna, AT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Laurenz Hauptmann

Medical University of Vienna, Vienna (Austria)
1 presentation
0 follower

8 more presentations in this session

Dysfunctional high-density lipoproteins in breast cancer patients and tumor-bearing mice treated with chemotherapy

Speaker: Professor S. Lecour (Cape Town, ZA)

Access
Abstract
Slides
Video
Like
Thumbnail

Low cardiovascular event rates in patients treated with CAR T-cells: real-world outcomes from two independent cohorts

Speaker: Mr J. Voran (Kiel, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Novel biomarker-based machine learning model in personalized cardiotoxicity prediction.

Speaker: Ms I. Liu (Austin, US)

Access
Abstract
Slides
Video
Like
Thumbnail

The incidence and risk factors for early onset atrial fibrillation in allogeneic and autologous hematopoietic stem cell transplant patients

Speaker: Ms L. Cai (Duarte, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Clinical and echocardiographic characteristics of neuroendocrine tumours and carcinoid heart disease: insights from a contemporary canadian cohort study

Speaker: Mr J. Yoon (Vancouver, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Special populations in cardio-oncology

Speakers: Doctor L. Hauptmann, Professor S. Lecour, Mr J. Voran, Ms I. Liu, Ms L. Cai...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources